Akèy › BPCO › Nevada › Las Vegas

Etid klinik pou BPCO nan Las Vegas, NV

5 etid pou BPCO ap chèche patisipan nan sit nan ak bò kote Las Vegas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Ap rekriteFaz 3

Excel Clinical Research - Las Vegas- Site Number : 8400070, Las Vegas

Laj 40 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07190222

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Ap rekriteFaz 3

Research Site, Las Vegas

Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06883305

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Ap rekriteFaz 3

Research Site, Las Vegas
Research Site, Las Vegas

Laj 40 a 80 · Tout sèks · Mizajou Aug 26, 2026 · NCT06283966

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Ap rekriteFaz 3

GSK Investigational Site, Las Vegas

Laj 40 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07177339

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Ap rekriteFaz 3

GSK Investigational Site, Las Vegas

Laj 40 a 80 · Tout sèks · Mizajou Apr 9, 2026 · NCT06961214

Etid BPCO nan lòt vil

Lòt etid nan Las Vegas

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.